Fortress Biotech, Inc. (FBIO)

NCM – Real Time Price. Currency in USD

2.76

+0.14 (5.56%)

Market open: Aug 12, 2026, 3:23 PM EDT

2.58

-0.03 (-1.27%)

Previous after-hours: Aug 11, 2026, 7:35 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

63M

58M

85M

76M

Cost of goods sold

-26M

-25M

-29M

-34M

Gross Profit

38M

32M

56M

42M

Operating expenses (excl. COGS)

-108M

-144M

-195M

-245M

Operating Income

-70M

-111M

-139M

-204M

Non-operating income, total

37M

-9M

-14M

-10M

Pretax income

-34M

-121M

-154M

-213M

Equity in earnings

Taxes

620K

-312K

-521K

-449K

Non-controlling/minority interest

40M

75M

94M

127M

After tax other income/expense

Net income before discontinued operations

-46M

-61M

-87M

Discontinued operations

Net income

-46M

-61M

-87M

Dilution adjustment

Preferred dividends

10M

Fortress Biotech, Inc. (FBIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Fortress Biotech, Inc. (FBIO)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Fortress Biotech, Inc. (FBIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Fortress Biotech, Inc. (FBIO)

Income Statement (Annual)

Income Statement (Annual)